BioAtla, Inc. (BCAB) stock
BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.31−0.05 (-3.68%)
Close on Oct 19, 2026Market cap $2.18MP/E –Yield –
BioAtla price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
BioAtla's price to book ratio was 38.3× on Jul 31, 2025, against 1.8× a year earlier. Over the last 5 years it ranged from 0.5× to 43.7×, with a median of 1.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 38.3× | +37.1 |
| 2024 | Dec 31, 2024 | 1.2× | +0.0 |
| 2023 | Dec 29, 2023 | 1.2× | −0.9 |
| 2022 | Dec 30, 2022 | 2.1× | −0.9 |
| 2021 | Dec 31, 2021 | 3.0× | – |
See a number that looks wrong?